Vicapsys Life Sciences, Inc. (VICP)

Vicapsys Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2009
Market Capitalization	289	31	35	26	17	12
Market Cap Growth	-	-13.41%	34.66%	53.32%	40.92%	-28.64%
Enterprise Value	289	31	35	26	17	15
PE Ratio	-107.36	-18.36	-258.01	-34.24	-12.13	-7.27
PS Ratio	-	-	-	-	-	1.56
PB Ratio	-77.38	-32.16	-290.29	-58.39	56.65	-4.44
P/FCF Ratio	-310.35	-128.37	-79.54	-99.75	-17.63	-8.26
P/OCF Ratio	-310.35	-128.37	-79.54	-99.75	-17.63	-8.70
EV/Sales Ratio	-	-	-	-	-	1.90
EV/EBITDA Ratio	-143.33	-111.94	-86.54	-35.71	-16.80	-12.01
EV/EBIT Ratio	-141.79	-100.43	-80.34	-34.24	-16.29	-10.92
EV/FCF Ratio	-311.11	-128.31	-79.05	-99.75	-17.36	-10.05
Debt / Equity Ratio	-0.23	0	0	0	0	-1.01
Debt / EBITDA Ratio	-0.43	-	-	-	-	-2.24
Debt / FCF Ratio	-0.92	-	-	-	-	-1.87
Quick Ratio	0.03	0.01	0.30	0.00	0.67	0.33
Current Ratio	0.14	0.07	0.31	0.00	0.67	0.51
Asset Turnover	0	0	0	0	0	3.49
Interest Coverage	-17.62	1.45	0	0	0	-4.20
Return on Equity (ROE)	106.47%	175.14%	112.51%	170.53%	-466.85%	61.08%
Return on Assets (ROA)	-681.17%	-2312.18%	-23.03%	-189.51%	-201.84%	-74.86%
Return on Capital (ROIC)	98.87%	103.58%	276.92%	170.53%	-342.40%	-8632.37%
Earnings Yield	-0.49%	-5.45%	-0.39%	-2.92%	-8.24%	-13.76%
FCF Yield	-0.12%	-0.78%	-1.26%	-1.00%	-5.67%	-12.11%
Buyback Yield / Dilution	-10.31%	-73.18%	-0.99%	-53.32%	-3188.17%	-1.94%
Total Shareholder Return	-10.31%	-73.18%	-0.99%	-53.32%	-3188.17%	-1.94%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.